News
Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback